JP2015500875A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500875A5
JP2015500875A5 JP2014548744A JP2014548744A JP2015500875A5 JP 2015500875 A5 JP2015500875 A5 JP 2015500875A5 JP 2014548744 A JP2014548744 A JP 2014548744A JP 2014548744 A JP2014548744 A JP 2014548744A JP 2015500875 A5 JP2015500875 A5 JP 2015500875A5
Authority
JP
Japan
Prior art keywords
biphenyl
dimethoxy
diol
motomeko
dipropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2014548744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/066053 external-priority patent/WO2013095364A1/en
Publication of JP2015500875A publication Critical patent/JP2015500875A/ja
Publication of JP2015500875A5 publication Critical patent/JP2015500875A5/ja
Ceased legal-status Critical Current

Links

JP2014548744A 2011-12-20 2011-12-20 マグノロール類似体を製造するための方法 Ceased JP2015500875A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/066053 WO2013095364A1 (en) 2011-12-20 2011-12-20 Processes for making magnolol analogs

Publications (2)

Publication Number Publication Date
JP2015500875A JP2015500875A (ja) 2015-01-08
JP2015500875A5 true JP2015500875A5 (enExample) 2015-02-19

Family

ID=45498120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548744A Ceased JP2015500875A (ja) 2011-12-20 2011-12-20 マグノロール類似体を製造するための方法

Country Status (15)

Country Link
US (1) US9045397B2 (enExample)
EP (1) EP2794535B1 (enExample)
JP (1) JP2015500875A (enExample)
CN (1) CN104066702B (enExample)
AR (1) AR089311A1 (enExample)
AU (1) AU2011383725B2 (enExample)
BR (1) BR112014015031A2 (enExample)
CA (1) CA2858817A1 (enExample)
MX (1) MX2014007554A (enExample)
PH (1) PH12014501327A1 (enExample)
RU (1) RU2014129908A (enExample)
SG (1) SG11201402852SA (enExample)
TW (1) TW201331173A (enExample)
WO (1) WO2013095364A1 (enExample)
ZA (1) ZA201404278B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9676690B2 (en) 2013-01-23 2017-06-13 Colgate-Palmolive Company Processes for making magnolol derivatives
CN105622603A (zh) * 2015-05-28 2016-06-01 广州牌牌生物科技有限公司 多核化合物、其制备方法以及其应用
CN109053387B (zh) * 2018-09-19 2021-07-09 九江学院 一种厚朴酚的合成方法
US12311044B2 (en) 2018-12-18 2025-05-27 Conopco, Inc. Antimicrobial composition
CN114956977B (zh) * 2022-06-09 2024-03-26 朗捷睿(苏州)生物科技有限公司 一种联苯类化合物、药物组合物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1106391C (zh) 1999-04-12 2003-04-23 李安荣 厚朴酚系列化合物及其合成方法和以该化合物为活性成分的药物组合物
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
JP4049696B2 (ja) 2003-03-27 2008-02-20 長谷川香料株式会社 ジアルキルビスフェノール類の製法
US7795233B2 (en) 2004-11-19 2010-09-14 Miyagi Ken Composition comprising double stranded RNA that inhibits expression of NEU3 and method for treating cancer
US7973185B2 (en) 2004-12-08 2011-07-05 Richter Gedeon Nyrt. Process for the preparation of phenolic hydroxy-substituted compounds
MY148519A (en) * 2004-12-29 2013-04-30 Colgate Palmolive Co Oral compositions containing biphenol antibacterial compounds
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
US7608741B2 (en) 2005-05-30 2009-10-27 Korea Institute Of Oriental Medicine Mass separation method of magnolol from Magnoliae cortex radix
JP4908070B2 (ja) * 2006-06-07 2012-04-04 長谷川香料株式会社 ジ−置換ビスフェノールの製造方法
WO2008006581A2 (en) 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
CN101293816B (zh) 2008-06-24 2011-09-28 江南大学 厚朴酚的合成方法
WO2010073124A2 (en) * 2008-12-26 2010-07-01 Actavis Group Ptc Ehf Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
TWI422382B (zh) 2010-02-24 2014-01-11 Colgate Palmolive Co 加強木蘭活性物之溶解度及傳送的組成物
TWI459957B (zh) 2010-02-24 2014-11-11 Colgate Palmolive Co 口腔保健組成物
RU2510938C1 (ru) 2010-02-25 2014-04-10 Колгейт-Палмолив Компани Синтез магнолола и его аналогов

Similar Documents

Publication Publication Date Title
JP2015500875A5 (enExample)
JP2014521673A5 (enExample)
JP2012528877A5 (enExample)
JP2010184824A5 (enExample)
JP2013512223A5 (enExample)
JP2013542935A5 (enExample)
WO2009065880A3 (de) Flammgeschützte expandierbare styrolpolymere und verfahren zu ihrer herstellung
JP2015530367A5 (enExample)
JP2007260659A5 (ja) 液相反応用のポリシラン担持遷移金属触媒
MX2014006249A (es) Metodo para producir y purificar sales del acido acrilamido - 2 - metilpropan sulfonico.
JP2016513709A5 (enExample)
JP2013508368A5 (enExample)
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
BR112014015962A2 (pt) métodos de produzir 4-amino-3-cloro-6-(4-cloro-2-fluoro-3-metoxifenil)piridina-2-carboxilato de metila
RU2014129908A (ru) Способы получения аналогов магнолола
JP2013100237A5 (enExample)
JP2015523337A5 (enExample)
JP2017509581A5 (enExample)
JP2008247919A5 (enExample)
JP2017522284A5 (enExample)
CN103787963A (zh) 高效制备4-二甲氨基吡啶
JP2013189391A5 (enExample)
JP2012017322A5 (enExample)
JP2014520066A5 (enExample)
CN103709210B (zh) 异丙基-β-D-硫代半乳糖苷的制备工艺